Professor Nicola Sibson of the Department of Oncology has been awarded a grant worth almost £200,000 by research charity Breast Cancer Now to fund cutting-edge research to uncover novel treatment combinations to control breast cancer that has spread to the brain.
About Oxford Centre
This author has yet to write their bio.Meanwhile lets just say that we are proud Oxford Centre contributed a whooping 66 entries.
Entries by Oxford Centre
John Findlay wins Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS) prize for his presentation ’Staging gastric cancer with 18F-FDG PET-CT identifies frequent unsuspected metastases and patients of high risk of incurable disease, early recurrence and death’
Today a new drug will become available for patients with bowel cancer as part of a national clinical trial; based on a scientific discovery made only two years ago at the University of Oxford.
Professor Tim Maughan, Professor of Clinical Oncology at the University of Oxford and Principal Lead of the S:CORT Consortium said: “This research emphasises how a collaborative approach can give significant insight into bowel cancer disease biology, but also to begin to translate this knowledge into clinically-relevant applications. As part of the work of the S:CORT consortium, we will now focus on making sure that the research is put into practice so that it can become part of the standard of care for patients.”
FOXFIRE Combined Analysis indicates no benefit in overall survival from adding selective internal radiotherapy [SIRT] to first-line oxaliplatin-based chemotherapy for metastatic colorectal cancer. Secondary analyses confirm improved control of liver metastases with liver-directed SIRT and show clinical benefit in patients with liver metastases originating from difficult-to-treat right-sided colon cancer.
The development of new treatments for pancreatic cancer is set to be transformed by a network of clinical trials, aiming to find the right trial for the right patient, after a £10 million investment from Cancer Research UK today.
Smokers treated for breast cancer have much higher risks than non-smokers of developing lung cancer or heart attack as a result of radiotherapy – according to a new study lead by the University of Oxford published in the Journal of Clinical Oncology.
The day will be a celebration of the wealth of excellence we have here in Oxford, and the passion and commitment to cancer research that is shared across our community. The 2017 symposium will focus on the themes of Prevent, Detect & Cure, and feature multidisciplinary speakers from across the University and Oxford University Hospitals NHS Foundation Trust. Register today!
For decades, scientists and doctors have looked for ways to stop the damage that viruses cause to humans. But in recent years, certain safe, modified viruses have emerged as potential allies to tackle cancer. Professor Len Seymour’s lab, at the Cancer Research UK Oxford Centre, has been focusing on one particular cancer-killing virus that operates under the code name of Enadenotucirev (or EnAd for short). Find out more in the CRUK Science Blog here.
Tagging gold nanoparticles with a small dose of radiation has helped researchers trace the precious metal as it delivers a drug right into the heart of cancer cells, according to new laboratory research being presented at the 2016 National Cancer Research Institute (NCRI) Cancer conference.
- Oxford University scientist developing new treatments to tackle breast cancer that has spread to the brainOctober 13, 2017 - 12:15 am
- John Findlay wins Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS) PrizeOctober 12, 2017 - 8:17 am
- From bench to bedside in two years: collaborative science opens the way for a new drug for bowel cancer patients across the UKJune 30, 2017 - 7:24 am